305 related articles for article (PubMed ID: 12211141)
1. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
[No Abstract] [Full Text] [Related]
2. DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S79-82. PubMed ID: 12211145
[No Abstract] [Full Text] [Related]
3. DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S74-8. PubMed ID: 12211144
[No Abstract] [Full Text] [Related]
4. DA agonists -- ergot derivatives: cabergoline: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S68-71. PubMed ID: 12211142
[No Abstract] [Full Text] [Related]
5. [Use of dopamine agonists in the treatment of Parkinson's disease].
Gekht AB
Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):54-8. PubMed ID: 12378886
[No Abstract] [Full Text] [Related]
6. Treatment of Parkinson's disease should begin with a dopamine agonist.
Montastruc JL; Rascol O; Senard JM
Mov Disord; 1999 Sep; 14(5):725-30. PubMed ID: 10495032
[TBL] [Abstract][Full Text] [Related]
7. DA agonists -- ergot derivatives: dihydroergocryptine (DHEC): management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S72-3. PubMed ID: 12211143
[No Abstract] [Full Text] [Related]
8. New options for treatment of Parkinson's disease.
LeWitt PA
Baillieres Clin Neurol; 1997 Apr; 6(1):109-23. PubMed ID: 9426871
[TBL] [Abstract][Full Text] [Related]
9. Dopamine agonists as primary treatment in Parkinson's disease.
Rinne UK
Adv Neurol; 1987; 45():519-23. PubMed ID: 3103394
[No Abstract] [Full Text] [Related]
10. Dopamine agonists and Parkinson's disease.
Burton K; Calne DB
Clin Neurol Neurosurg; 1984; 86(3):172-7. PubMed ID: 6091965
[TBL] [Abstract][Full Text] [Related]
11. New pharmacotherapy for Parkinson's disease.
Gottwald MD; Bainbridge JL; Dowling GA; Aminoff MJ; Alldredge BK
Ann Pharmacother; 1997 Oct; 31(10):1205-17. PubMed ID: 9337447
[TBL] [Abstract][Full Text] [Related]
12. DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S83-9. PubMed ID: 12211146
[No Abstract] [Full Text] [Related]
13. Pergolide and Parkinson's disease: new preparation. No clear benefit.
Prescrire Int; 2000 Dec; 9(50):177-9. PubMed ID: 11475497
[TBL] [Abstract][Full Text] [Related]
14. Dopamine agonists in Parkinson's disease.
Calne DB; Burton K; Beckman J; Martin WR
Can J Neurol Sci; 1984 Feb; 11(1 Suppl):221-4. PubMed ID: 6231979
[TBL] [Abstract][Full Text] [Related]
15. [Dopamine agonist in the treatment of Parkinson's disease].
Kuran W
Neurol Neurochir Pol; 1997; 31(3):545-54. PubMed ID: 9446045
[TBL] [Abstract][Full Text] [Related]
16. Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations.
Widnell KL; Comella C
Mov Disord; 2005; 20 Suppl 11():S30-7. PubMed ID: 15822107
[TBL] [Abstract][Full Text] [Related]
17. Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group study.
Ries V; Selzer R; Eichhorn T; Oertel WH; Eggert K;
Clin Neuropharmacol; 2010 May; 33(3):142-50. PubMed ID: 20502133
[TBL] [Abstract][Full Text] [Related]
18. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
Rinne UK
Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430
[No Abstract] [Full Text] [Related]
19. A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
Bonnet AM; Serre I; Marconi R; Agid Y; Dubois B
Mov Disord; 1995 Sep; 10(5):668-71. PubMed ID: 8552122
[TBL] [Abstract][Full Text] [Related]
20. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
Kim JY; Chung EJ; Park SW; Lee WY
Mov Disord; 2006 Aug; 21(8):1261-4. PubMed ID: 16685692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]